To investigate whether CRY1-mediated inhibition of glycolysis could be achieved in different cells, we selected a breast cancer cell line MDA-MB-231 in which glycolysis and its stem cell properties were associated with the PDK1 level (32) and generated a cell line expressing exogenous CRY1 constitutively. Here, PDK1 is linked to breast cancer.